Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 421 - 440 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
Reset 

Immunovant Announces Pricing of $450 Million Common Stock Financing

Read more ››
By: GlobeNewswire - 28 Sep 2023

Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Antengene Corporation

BIOHK2023 LEAVES A MARK ON BIOTECH COMMUNITY: MUST-KNOW HIGHLIGHTS

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

ScolioLife® Scoliosis & Spine Correction Clinic: A Beacon of Hope for Patients

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  ScolioLife Pte Ltd

BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

Base Pair Bio Receives Grant from NIH to Help Deliver Therapies for Genetic Heart Disease

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Base Pair Biotechnologies, Inc

Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Akeso Biomedical, Inc. | Akeso Ventures Inc

BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  BrainStorm Cell Therapeutics Inc.

Capita3 Announces Acquisition of Portfolio Company EmpowerU by FullBloom to Help Young People Thrive in Academics and Life

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  MediciNova, Inc.

Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Ocugen, Inc.

Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Everest Medicines (Shanghai)

Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Inovio Pharmaceuticals, Inc.

PAs across Canada applaud BC Government move to introduce Physician Assistants

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

Acuitive Technologies Receives FDA 510(k) Clearance for CITRELOCK DUO a New Sports Medicine Fixation Device for Biceps Tenodesis and Tendon Transfer Procedures

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Acuitive Technologies Inc.

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Iovance Biotherapeutics, Inc.

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Gritstone bio

Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Soleno Therapeutics, Inc.

Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Sagimet Biosciences

Option Care Health to Announce Third Quarter 2023 Financial Results and Host Conference Call

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Option Care Health Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21 22  23  24  25 »
to the top ↑